Utilizing large-scale electronic health records (EHR) and insurance claims databases (e.g., TriNetX), these studies evaluated the comparative effectiveness of tirzepatide vs
GLP1 agonists like Semaglutide, Liraglutide may increase risk of pancreatitis, gastroparesis and bowel obstruction US: Researchers at University of British Columbia have found in a new study that that use of glucagon-like peptide-1 agonists for weight loss compared with use of bupropion-naltrexone was associated with increased risk of pancreatitis, gastroparesis, and bowel obstruction but not biliary disease
Lauren Leavitt, M.D
Nausea, delayed gastric emptying
Lee SM, Bustamante SA, Koldovsky O
Timeline of Ozempic Side Effects by Severity The temporal pattern of Ozempic side effects follows a generally predictable trajectory, though individual experiences vary